Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised KKR in connection with the acquisition of Gunnebo Industrier
Mandate

Vinge has advised KKR in connection with the acquisition of Gunnebo Industrier

May 22, 2019 M&A

Vinge has advised the global investment company, KKR in connection with the acquisition by its portfolio company Crosby of Gunnebo Industrier from Segulah and minority investors.

Crosby is a global, market‑leading company with products within lifting and rigging. Gunnebo Industrier is an international manufacturing group that provides lifting and material handling products to a global customer base. The company was founded in 1764 and has manufacturing units in Sweden, Norway and the USA with subsidiaries in nine countries and distribution partners in more than 50 countries.

Vinge’s team consisted of, among others, Christina Kokko, Samra Baytar, Marith Welin-Berger and Hanna Risberg (Corporate and M&A), Adriana Berglund and Michael Montner (Commercial Agreements), Lisa Ullman (Employment), André Isacson and Josefine Larsson (Banking and Finance), Klara Secher and Hannah Kajlinger (IP), Kristoffer Larson (Real Property), Agnes Perbo and Nicklas Thorgerzon (IT) and Jessica Öijer (VDR assistant).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025